Granite Investment Partners LLC Has $6.91 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Granite Investment Partners LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,566 shares of the healthcare conglomerate’s stock after selling 943 shares during the period. Granite Investment Partners LLC’s holdings in UnitedHealth Group were worth $6,909,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Aveo Capital Partners LLC increased its holdings in UnitedHealth Group by 23.8% in the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock valued at $1,139,000 after buying an additional 416 shares during the period. 9258 Wealth Management LLC lifted its stake in UnitedHealth Group by 7.3% during the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after purchasing an additional 290 shares during the last quarter. Gryphon Financial Partners LLC increased its stake in shares of UnitedHealth Group by 80.9% in the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock valued at $3,275,000 after purchasing an additional 2,782 shares during the last quarter. TrinityPoint Wealth LLC boosted its stake in UnitedHealth Group by 102.8% in the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after buying an additional 7,489 shares in the last quarter. Finally, Quest Partners LLC acquired a new position in UnitedHealth Group during the fourth quarter worth about $668,000. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $577.10 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The firm has a 50 day moving average of $575.84 and a 200-day moving average of $519.83. The company has a market cap of $532.91 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the business earned $6.14 earnings per share. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.46%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Truist Financial increased their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. HSBC raised their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, Royal Bank of Canada upped their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.